Central administration of C-X-C chemokine receptor type 4 antagonist alleviates the development and maintenance of peripheral neuropathic pain in mice.
<h4>Aim</h4>To explore the roles of C-X-C chemokine receptor type 4 (CXCR4) in spinal processing of neuropathic pain at the central nervous system (CNS).<h4>Methods</h4>Peripheral neuropathic pain (PNP) induced by partial sciatic nerve ligation (pSNL) model was assessed in mi...
Saved in:
Main Authors: | Xin Luo, Wai Lydia Tai, Liting Sun, Qiu Qiu, Zhengyuan Xia, Sookja Kim Chung, Chi Wai Cheung |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/baece4fdcba340a095d59d3f96ca0ab4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice
by: Cyril Rivat, et al.
Published: (2018) -
Therapeutic Effect of C-C Chemokine Receptor Type 1 (CCR1) Antagonist BX471 on Allergic Rhinitis
by: Feng S, et al.
Published: (2020) -
Neurogenesis in the adult brain functionally contributes to the maintenance of chronic neuropathic pain
by: Linette Liqi Tan, et al.
Published: (2021) -
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
by: Russell J, et al.
Published: (2010) -
Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine
by: Lindsay Zilliox, et al.
Published: (2010)